Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.
Sumida Y, Kanemasa K, Imai S, Mori K, Tanaka S, Shimokobe H, Kitamura Y, Fukumoto K, Kakutani A, Ohno T, Taketani H, Seko Y, Ishiba H, Hara T, Okajima A, Yamaguchi K, Moriguchi M, Mitsuyoshi H, Yasui K, Minami M, Itoh Y. Sumida Y, et al. Among authors: itoh y. J Gastroenterol. 2015 Sep;50(9):996-1004. doi: 10.1007/s00535-015-1039-2. Epub 2015 Jan 28. J Gastroenterol. 2015. PMID: 25622927
[Autoimmune disorders in interferon therapy].
Okanoue T, Itoh Y, Yasui K. Okanoue T, et al. Among authors: itoh y. Nihon Rinsho. 1994 Jul;52(7):1924-8. Nihon Rinsho. 1994. PMID: 7521440 Review. Japanese.
Role of sinusoidal endothelial cells in liver disease.
Okanoue T, Mori T, Sakamoto S, Itoh Y. Okanoue T, et al. Among authors: itoh y. J Gastroenterol Hepatol. 1995;10 Suppl 1:S35-7. doi: 10.1111/j.1440-1746.1995.tb01794.x. J Gastroenterol Hepatol. 1995. PMID: 8589339
Side effects of high-dose interferon therapy for chronic hepatitis C.
Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H, Sawa Y, Mizuno M, Kagawa K, Kashima K. Okanoue T, et al. Among authors: itoh y. J Hepatol. 1996 Sep;25(3):283-91. doi: 10.1016/s0168-8278(96)80113-9. J Hepatol. 1996. PMID: 8895006
Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group.
Okanoue T, Itoh Y, Minami M, Sakamoto S, Yasui K, Sakamoto M, Nishioji K, Murakami Y, Kashima K. Okanoue T, et al. Among authors: itoh y. J Hepatol. 1999 Apr;30(4):653-9. doi: 10.1016/s0168-8278(99)80196-2. J Hepatol. 1999. PMID: 10207807 Clinical Trial.
3,308 results